NCT06955988
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of AST2303 Tablets (ABK3376 Tablets) in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer
Phase: Phase 1
Role: Lead Sponsor
Start: Mar 4, 2025
Completion: Jun 30, 2027